Cargando…

Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke

The role of metabolic diseases in ischemic stroke has become a primary concern in both research and clinical practice. Increasing evidence suggests that dysbiosis is associated with metabolic diseases. The aim of this study was to investigate whether the gut microbiota, as well as concentrations of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashiro, Kazuo, Tanaka, Ryota, Urabe, Takao, Ueno, Yuji, Yamashiro, Yuichiro, Nomoto, Koji, Takahashi, Takuya, Tsuji, Hirokazu, Asahara, Takashi, Hattori, Nobutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293236/
https://www.ncbi.nlm.nih.gov/pubmed/28166278
http://dx.doi.org/10.1371/journal.pone.0171521
_version_ 1782505045208596480
author Yamashiro, Kazuo
Tanaka, Ryota
Urabe, Takao
Ueno, Yuji
Yamashiro, Yuichiro
Nomoto, Koji
Takahashi, Takuya
Tsuji, Hirokazu
Asahara, Takashi
Hattori, Nobutaka
author_facet Yamashiro, Kazuo
Tanaka, Ryota
Urabe, Takao
Ueno, Yuji
Yamashiro, Yuichiro
Nomoto, Koji
Takahashi, Takuya
Tsuji, Hirokazu
Asahara, Takashi
Hattori, Nobutaka
author_sort Yamashiro, Kazuo
collection PubMed
description The role of metabolic diseases in ischemic stroke has become a primary concern in both research and clinical practice. Increasing evidence suggests that dysbiosis is associated with metabolic diseases. The aim of this study was to investigate whether the gut microbiota, as well as concentrations of organic acids, the major products of dietary fiber fermentation by the gut microbiota, are altered in patients with ischemic stroke, and to examine the association between these changes and host metabolism and inflammation. We analyzed the composition of the fecal gut microbiota and the concentrations of fecal organic acids in 41 ischemic stroke patients and 40 control subjects via 16S and 23S rRNA-targeted quantitative reverse transcription (qRT)-PCR and high-performance liquid chromatography analyses, respectively. Multivariable linear regression analysis was subsequently performed to evaluate the relationships between ischemic stroke and bacterial counts and organic acid concentrations. Correlations between bioclinical markers and bacterial counts and organic acids concentrations were also evaluated. Although only the bacterial counts of Lactobacillus ruminis were significantly higher in stroke patients compared to controls, multivariable analysis showed that ischemic stroke was independently associated with increased bacterial counts of Atopobium cluster and Lactobacillus ruminis, and decreased numbers of Lactobacillus sakei subgroup, independent of age, hypertension, and type 2 diabetes. Changes in the prevalence of Lactobacillus ruminis were positively correlated with serum interleukin-6 levels. In addition, ischemic stroke was associated with decreased and increased concentrations of acetic acid and valeric acid, respectively. Meanwhile, changes in acetic acid concentrations were negatively correlated with the levels of glycated hemoglobin and low-density lipoprotein cholesterol, whereas changes in valeric acid concentrations were positively correlated with the level of high sensitivity C-reactive protein and with white blood cell counts. Together, our findings suggest that gut dysbiosis in patients with ischemic stroke is associated with host metabolism and inflammation.
format Online
Article
Text
id pubmed-5293236
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52932362017-02-17 Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke Yamashiro, Kazuo Tanaka, Ryota Urabe, Takao Ueno, Yuji Yamashiro, Yuichiro Nomoto, Koji Takahashi, Takuya Tsuji, Hirokazu Asahara, Takashi Hattori, Nobutaka PLoS One Research Article The role of metabolic diseases in ischemic stroke has become a primary concern in both research and clinical practice. Increasing evidence suggests that dysbiosis is associated with metabolic diseases. The aim of this study was to investigate whether the gut microbiota, as well as concentrations of organic acids, the major products of dietary fiber fermentation by the gut microbiota, are altered in patients with ischemic stroke, and to examine the association between these changes and host metabolism and inflammation. We analyzed the composition of the fecal gut microbiota and the concentrations of fecal organic acids in 41 ischemic stroke patients and 40 control subjects via 16S and 23S rRNA-targeted quantitative reverse transcription (qRT)-PCR and high-performance liquid chromatography analyses, respectively. Multivariable linear regression analysis was subsequently performed to evaluate the relationships between ischemic stroke and bacterial counts and organic acid concentrations. Correlations between bioclinical markers and bacterial counts and organic acids concentrations were also evaluated. Although only the bacterial counts of Lactobacillus ruminis were significantly higher in stroke patients compared to controls, multivariable analysis showed that ischemic stroke was independently associated with increased bacterial counts of Atopobium cluster and Lactobacillus ruminis, and decreased numbers of Lactobacillus sakei subgroup, independent of age, hypertension, and type 2 diabetes. Changes in the prevalence of Lactobacillus ruminis were positively correlated with serum interleukin-6 levels. In addition, ischemic stroke was associated with decreased and increased concentrations of acetic acid and valeric acid, respectively. Meanwhile, changes in acetic acid concentrations were negatively correlated with the levels of glycated hemoglobin and low-density lipoprotein cholesterol, whereas changes in valeric acid concentrations were positively correlated with the level of high sensitivity C-reactive protein and with white blood cell counts. Together, our findings suggest that gut dysbiosis in patients with ischemic stroke is associated with host metabolism and inflammation. Public Library of Science 2017-02-06 /pmc/articles/PMC5293236/ /pubmed/28166278 http://dx.doi.org/10.1371/journal.pone.0171521 Text en © 2017 Yamashiro et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Yamashiro, Kazuo
Tanaka, Ryota
Urabe, Takao
Ueno, Yuji
Yamashiro, Yuichiro
Nomoto, Koji
Takahashi, Takuya
Tsuji, Hirokazu
Asahara, Takashi
Hattori, Nobutaka
Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
title Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
title_full Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
title_fullStr Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
title_full_unstemmed Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
title_short Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
title_sort gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293236/
https://www.ncbi.nlm.nih.gov/pubmed/28166278
http://dx.doi.org/10.1371/journal.pone.0171521
work_keys_str_mv AT yamashirokazuo gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT tanakaryota gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT urabetakao gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT uenoyuji gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT yamashiroyuichiro gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT nomotokoji gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT takahashitakuya gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT tsujihirokazu gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT asaharatakashi gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke
AT hattorinobutaka gutdysbiosisisassociatedwithmetabolismandsystemicinflammationinpatientswithischemicstroke